Transcription factor NF-kB is activated in primary neurons by amyloid ß peptides and in neurons surrounding early plaques from patients with Alzheimer disease

Kaltschmidt B, Uherek M, Volk B, Baeuerle PA, Kaltschmidt C (1997)
Proc. Natl. Acad. Sci. USA 94(6): 2642-2647.

Download
Es wurde kein Volltext hochgeladen. Nur Publikationsnachweis!
Zeitschriftenaufsatz | Veröffentlicht | Englisch
Autor
; ; ; ;
Erscheinungsjahr
Zeitschriftentitel
Proc. Natl. Acad. Sci. USA
Band
94
Zeitschriftennummer
6
Seite
2642-2647
ISSN
PUB-ID

Zitieren

Kaltschmidt B, Uherek M, Volk B, Baeuerle PA, Kaltschmidt C. Transcription factor NF-kB is activated in primary neurons by amyloid ß peptides and in neurons surrounding early plaques from patients with Alzheimer disease. Proc. Natl. Acad. Sci. USA. 1997;94(6):2642-2647.
Kaltschmidt, B., Uherek, M., Volk, B., Baeuerle, P. A., & Kaltschmidt, C. (1997). Transcription factor NF-kB is activated in primary neurons by amyloid ß peptides and in neurons surrounding early plaques from patients with Alzheimer disease. Proc. Natl. Acad. Sci. USA, 94(6), 2642-2647.
Kaltschmidt, B., Uherek, M., Volk, B., Baeuerle, P. A., and Kaltschmidt, C. (1997). Transcription factor NF-kB is activated in primary neurons by amyloid ß peptides and in neurons surrounding early plaques from patients with Alzheimer disease. Proc. Natl. Acad. Sci. USA 94, 2642-2647.
Kaltschmidt, B., et al., 1997. Transcription factor NF-kB is activated in primary neurons by amyloid ß peptides and in neurons surrounding early plaques from patients with Alzheimer disease. Proc. Natl. Acad. Sci. USA, 94(6), p 2642-2647.
B. Kaltschmidt, et al., “Transcription factor NF-kB is activated in primary neurons by amyloid ß peptides and in neurons surrounding early plaques from patients with Alzheimer disease”, Proc. Natl. Acad. Sci. USA, vol. 94, 1997, pp. 2642-2647.
Kaltschmidt, B., Uherek, M., Volk, B., Baeuerle, P.A., Kaltschmidt, C.: Transcription factor NF-kB is activated in primary neurons by amyloid ß peptides and in neurons surrounding early plaques from patients with Alzheimer disease. Proc. Natl. Acad. Sci. USA. 94, 2642-2647 (1997).
Kaltschmidt, Barbara, Uherek, M., Volk, B., Baeuerle, P.A., and Kaltschmidt, Christian. “Transcription factor NF-kB is activated in primary neurons by amyloid ß peptides and in neurons surrounding early plaques from patients with Alzheimer disease”. Proc. Natl. Acad. Sci. USA 94.6 (1997): 2642-2647.

295 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Activation of NF-kappa B by reactive oxygen intermediates in the nervous system.
Kaltschmidt B, Sparna T, Kaltschmidt C., Antioxid Redox Signal 1(2), 1999
PMID: 11228742
Regulation of amyloid precursor protein cleavage.
Mills J, Reiner PB., J Neurochem 72(2), 1999
PMID: 9930716
Activation of nuclear factor-kappaB in the rat brain after transient focal ischemia.
Gabriel C, Justicia C, Camins A, Planas AM., Brain Res Mol Brain Res 65(1), 1999
PMID: 10036308
Alzheimer's disease and brain development: common molecular pathways.
Jordan-Sciutto K, Bowser R., Front Biosci 3(), 1998
PMID: 9422711
Early glycoxidation damage in brains from Down's syndrome.
Odetti P, Angelini G, Dapino D, Zaccheo D, Garibaldi S, Dagna-Bricarelli F, Piombo G, Perry G, Smith M, Traverso N, Tabaton M., Biochem Biophys Res Commun 243(3), 1998
PMID: 9501012
NF-kappaB modulates lipopolysaccharide-induced microglial nerve growth factor expression.
Heese K, Fiebich BL, Bauer J, Otten U., Glia 22(4), 1998
PMID: 9517572
Amyloid beta-peptide stimulates nitric oxide production in astrocytes through an NFkappaB-dependent mechanism.
Akama KT, Albanese C, Pestell RG, Van Eldik LJ., Proc Natl Acad Sci U S A 95(10), 1998
PMID: 9576964
NF-kB immunoreactivity is observed in association with beta A4 diffuse plaques in patients with Alzheimer's disease.
Ferrer I, Martí E, López E, Tortosa A., Neuropathol Appl Neurobiol 24(4), 1998
PMID: 9775392
Expression of FAC1 in activated microglia during Alzheimer's disease.
Bowser R, Reilly S., Neurosci Lett 253(3), 1998
PMID: 9792236
Familial Alzheimer's disease: oxidative stress, beta-amyloid, presenilins, and cell death.
Velez-Pardo C, Jimenez Del Rio M, Lopera F., Gen Pharmacol 31(5), 1998
PMID: 9809462
Nuclear factor kappa B: important transcription factor and therapeutic target.
Lee JI, Burckart GJ., J Clin Pharmacol 38(11), 1998
PMID: 9824778
NF-kappa B: a crucial transcription factor for glial and neuronal cell function.
O'Neill LA, Kaltschmidt C., Trends Neurosci 20(6), 1997
PMID: 9185306
Gene expression induced by cerebral ischemia: an apoptotic perspective.
MacManus JP, Linnik MD., J Cereb Blood Flow Metab 17(8), 1997
PMID: 9290580
Antioxidant defense of the brain: a role for astrocytes.
Wilson JX., Can J Physiol Pharmacol 75(10-11), 1997
PMID: 9431439
Alteration of transcription factors NF-kappaB and STAT1 in Alzheimer's disease brains.
Kitamura Y, Shimohama S, Ota T, Matsuoka Y, Nomura Y, Taniguchi T., Neurosci Lett 237(1), 1997
PMID: 9406869

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 9122249
PubMed | Europe PMC

Suchen in

Google Scholar